Real-world treatment patterns of patients with low-risk MDS reinitiating ESAs VJHemOnc – Video Journal of Hematology & HemOnc 1:14 2 years ago 123 Далее Скачать
The current standard of care for patients with lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 1:20 2 years ago 125 Далее Скачать
Luspatercept for the treatment of patients with lower-risk MDS and ESA failure VJHemOnc – Video Journal of Hematology & HemOnc 1:15 1 year ago 1 101 Далее Скачать
The role of ESAs agents in low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 2:04 2 years ago 33 Далее Скачать
The promise of luspatercept for the treatment of lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 0:56 1 year ago 152 Далее Скачать
The impact of ESAs in lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 1:48 2 years ago 52 Далее Скачать
MDS: treating high and low-risk disease VJHemOnc – Video Journal of Hematology & HemOnc 3:15 5 years ago 426 Далее Скачать
KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with RRMM International Myeloma Foundation 8:31 4 years ago 285 Далее Скачать
Novel Treatment Strategies in Low-Risk MDS: Case Study HMP Education 18:42 3 years ago 212 Далее Скачать
The unmet needs in low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 0:55 6 years ago 162 Далее Скачать
Treatment algorithm for low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 11:33 4 years ago 288 Далее Скачать
Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting* Practice Point Communications 12:22 2 years ago 56 Далее Скачать
The need to incorporate disease-modifying drugs in lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 0:52 1 year ago 86 Далее Скачать
Promising treatment options emerging for higher-risk MDS & the value of clinical trials VJHemOnc – Video Journal of Hematology & HemOnc 3:31 1 year ago 229 Далее Скачать
The optimal treatment of lower risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 11:53 3 years ago 1 621 Далее Скачать
Managing adverse events with novel therapies in lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 56 Далее Скачать
Promising agents under investigation for low and high-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 3:46 1 year ago 236 Далее Скачать
Novel therapies in low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 4:12 3 years ago 630 Далее Скачать
Improving the treatment of low-risk MDS: luspatercept, treatment sequencing & disease classification VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 571 Далее Скачать
